Is Hainan Haiyao a blockchain
the majority shareholder believes that his shares should be worth at least 10 yuan,
less than 10 yuan, and that his shares can be sold (originally, they can be sold after the share reform) and will not be sold.
to show his determination
Haiyao is a high-tech enterprise in Hainan Province, with provincial technology center, pilot plant, testing center and R & D center. There are three ways for enterprises to develop new procts: one is to develop new procts by themselves; Second, cooperate with domestic scientific research institutions and colleges to develop new procts; Third, cooperate with foreign institutions to develop new procts. Haipyrene has developed more than 30 kinds of new procts, including 15 national new procts such as Hongbao, changweikang and paclitaxel, and has won national, provincial and municipal science and technology progress awards for many times. At the same time, we cooperated with Tsinghua University and Fudan University to develop several national class I and class II new drugs. The new drug R & D center established by China Pharmaceutical University and Haiyao will bring new vitality to the development and innovation of new procts
proct quality is the life of an enterprise. The pharmaceutical factory implements management in strict accordance with GMP standards, and scientifically and effectively controls the whole process of quality management from proct development to after-sales service. The 45 instrial and quality control points of the plant are managed by monitoring system, and the quality control center is equipped with precision testing instruments imported from the United States, Japan and other countries. These advanced testing means, strict monitoring proceres, and GMP management permeate every post on the site, forming a strict quality management system. Firmly monitoring the entire proction process, to provide a strong guarantee for proct quality. The factory also has a bioengineering workshop and a provincial technology development center. It provides convenient conditions for enterprises to develop new procts
On August 8, 1992, the company was reorganized and established on the basis of the original Haikou pharmaceutical factory with the approval of Hainan Provincial joint stock pilot leading group office [qionggubanzi [1992] No. 10]. The company obtained the business license of enterprise legal person issued by Hainan Administration for Instry and Commerce on December 30, 1992. In December 1993, it was reviewed and approved by China Securities Regulatory Commission [zjfsz [1993] NO.115] and Shenzhen Stock Exchange [szszsz [1994] No.002]. It issued 25 million RMB ordinary shares and was listed and circulated in Shenzhen Stock Exchange in May 1994